Last quarter (Q3 2022), Todos Medical's total revenue was $1.91M, an increase of 89.50% from the same quarter last year. In Q3, Todos Medical's net income was $-5.63M. See Todos Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 10.75M	$ 12.23M	$ 5.21M	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	$ 6.27M	$ 7.85M	$ 3.82M	$ 0.00	-	-
Gross Profit	$ 4.48M	$ 4.38M	$ 1.39M	$ 0.00	-	-
Operating Expense	$ 12.89M	$ 13.67M	$ 15.65M	$ 3.52M	$ 1.38M	$ 1.34M
Operating Income	$ -8.41M	$ -9.29M	$ -14.26M	$ -3.52M	$ -1.38M	$ -1.34M
Net Non Operating Interest Income Expense	$ -21.91M	-	$ -14.31M	$ -3.35M	$ -50.00K	$ -166.50K
Other Income Expense	$ -7.58M	$ 1.66M	$ 1.20M	$ -4.95M	$ 971.34K	$ -1.17M
Pretax Income	$ -38.68M	$ -10.94M	$ -15.46M	$ -11.81M	$ -457.54K	$ -2.68M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -38.77M	$ -43.31M	$ -29.77M	$ -11.81M	$ -457.54K	$ -2.64M
Basic EPS	$ -0.03	-	-	$ -0.13	$ -0.01	$ -0.04
Diluted EPS	$ -0.03	$ -0.06	$ -0.11	$ -0.13	$ -0.01	$ -0.04
Basic Average Shares	$ 3.28B	$ 679.57M	$ 259.18M	$ 92.02M	$ 70.87M	$ 68.59M
Diluted Average Shares	$ 3.28B	$ 679.57M	$ 259.18M	$ 92.02M	$ 70.87M	$ 68.59M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	$ 149.42K	-	-	-	-	$ 14.73K
Total Expenses	$ 19.16M	$ 21.52M	$ 19.47M	$ 3.52M	$ 1.38M	$ 1.34M
Net Income From Continuing And Discontinued Operation	$ -38.83M	$ -43.31M	$ -29.77M	$ -11.81M	$ -457.54K	$ -2.68M
Normalized Income	$ -18.54M	-	-	$ -9.84M	$ -1.43M	$ -1.50M
Interest Expense	$ 13.83M	-	-	$ 959.00K	$ 0.00	-
EBIT	$ -16.59M	$ -10.94M	$ -15.46M	$ -10.86M	$ -457.54K	$ -1.34M
EBITDA	$ -9.02M	$ -7.52M	$ -14.20M	$ -10.83M	$ -432.04K	$ -1.31M

Currency in USD

Todos Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing